Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research

Volume: 26, Issue: 4, Pages: 375 - 382
Published: Jan 28, 2020
Abstract
Pancreatic ductal adenocarcinoma is an aggressive cancer with high recurrence rates following surgical resection. While adjuvant chemotherapy improves survival, a significant proportion of patients are unable to initiate or complete all intended therapy following pancreatectomy due to postoperative complications or poor performance status. The administration of chemotherapy prior to surgical resection is an alternative strategy that ensures its...
Paper Details
Title
Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
Published Date
Jan 28, 2020
Volume
26
Issue
4
Pages
375 - 382
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.